Japan Bioplastics Market Summary, Competitive Analysis and Forecast to 2027

Summary


Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include haematology, haemostasis, and urinalysis analyzers. It conducts research and development at its facilities in Japan, France, New Zealand, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa, and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Sysmex Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Category segmentation
1.6. Geography segmentation
1.7. Market rivalry
1.8. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the key strengths of the leading players?
7.3. What are the most recent notable developments of the leading players?
8 Company Profiles
8.1. Genomatica Inc
8.2. Mitsubishi Chemical Group Corporation
8.3. Resonac Corporation
8.4. Futamura Chemical Co Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related GlobalData research
About GlobalData
List of Tables
Table 1: Japan bioplastics market value: $ million, 2017–22
Table 2: Japan bioplastics market volume: thousand Tonnes, 2017–22
Table 3: Japan bioplastics market category segmentation: % share, by value, 2017–2022
Table 4: Japan bioplastics market category segmentation: $ million, 2017-2022
Table 5: Japan bioplastics market geography segmentation: $ million, 2022
Table 6: Japan bioplastics market value forecast: $ million, 2022–27
Table 7: Japan bioplastics market volume forecast: thousand Tonnes, 2022–27
Table 8: Genomatica Inc: key facts
Table 9: Genomatica Inc: key employees
Table 10: Mitsubishi Chemical Group Corporation: key facts
Table 11: Mitsubishi Chemical Group Corporation: annual financial ratios
Table 12: Mitsubishi Chemical Group Corporation: key employees
Table 13: Mitsubishi Chemical Group Corporation: key employees Continued
Table 14: Mitsubishi Chemical Group Corporation: key employees Continued
Table 15: Resonac Corporation: key facts
Table 16: Resonac Corporation: key employees
Table 17: Resonac Corporation: key employees Continued
Table 18: Futamura Chemical Co Ltd: key facts
Table 19: Futamura Chemical Co Ltd: key employees
Table 20: Japan size of population (million), 2018–22
Table 21: Japan gdp (constant 2005 prices, $ billion), 2018–22
Table 22: Japan gdp (current prices, $ billion), 2018–22
Table 23: Japan inflation, 2018–22
Table 24: Japan consumer price index (absolute), 2018–22
Table 25: Japan exchange rate, 2018–22
List of Figures
Figure 1: Japan bioplastics market value: $ million, 2017–22
Figure 2: Japan bioplastics market volume: thousand Tonnes, 2017–22
Figure 3: Japan bioplastics market category segmentation: $ million, 2017-2022
Figure 4: Japan bioplastics market geography segmentation: % share, by value, 2022
Figure 5: Japan bioplastics market value forecast: $ million, 2022–27
Figure 6: Japan bioplastics market volume forecast: thousand Tonnes, 2022–27
Figure 7: Forces driving competition in the bioplastics market in Japan, 2022
Figure 8: Drivers of buyer power in the bioplastics market in Japan, 2022
Figure 9: Drivers of supplier power in the bioplastics market in Japan, 2022
Figure 10: Factors influencing the likelihood of new entrants in the bioplastics market in Japan, 2022
Figure 11: Factors influencing the threat of substitutes in the bioplastics market in Japan, 2022
Figure 12: Drivers of degree of rivalry in the bioplastics market in Japan, 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings